Table 1 Enrollment criteria for the MAGIC Cell-5-Combination Cytokine Trial.

   Age: 18 to 80 years

   Able to verbally confirm understandings of risks, benefits, and treatment alternatives of receiving the cell therapy provides written informed consent before any study-related procedure

   ST-segment elevation acute myocardial infarction

   Successful revascularization of culprit vessel

Exclusion criteria

   Known hypersensitivity or contraindication to any of the following medications:

   Heparin, aspirin, clopidogrel, sirolimus, everolimus, contrast media

   Uncontrolled congestive heart failure (patients with LVEF <20% or Killip class II, III or those with cardiogenic shock)

   Uncontrolled myocardial ischemia (repeated chest pain or dyspnea after revascularization)

   Uncontrolled ventricular arrhythmia

   History of malignancy

   Serious hematologic disease

   Current infectious disease needs antibiotics therapy

   Creatinine level >2.0 mg/dL or dependence on dialysis